We are Ethyl 4-oxocyclohexanecarboxylate CAS:17159-79-4 manufacturer and supplier in China, Pls send inquiry of to email@example.com of visit www.nbinno.com our official website should you have any interests
Chemical Name: Ethyl 4-oxocyclohexanecarboxylate
4-Oxocyclohexanecarboxylic Acid Ethyl Ester
Physical and Chemical Properties:
Density: 1.068 g / mL at 25 ° C (lit.)
Boiling point: 150-152 ° C40 mm Hg (lit.)
Flash point:> 230 ° F
Refractive index: n20 / D 1.461 (lit.)
Sulfated ash:0.1% Max.
Heavy metals:10ppm Max
Total Impurity:0.2% Max.
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a tightly closed container. Store in a cool, dry, well-ventilated area away from incompatible substances.
Application:A cyclohexanone derivative used in the study of cyclohexanone monooxygenase and its mutants as catalysts.
Related News: From basic chemical raw materials to chemical preparations, complex chemical and physical processes are required. The production of chemical raw materials and intermediates concentrates the main synthetic procedures and technical links, which is the prerequisite and important guarantee for the development of the chemical pharmaceutical industry.L-4-Nitrophenylalanine methyl ester hydrochloride The insulin-only and bihormonal configurations may be helpful in diabetes.Metiltris (metiletilcetoxima) silano CAS:22984-54-9 According to statistics, in 2017, China’s total production of chemical drugs reached 3.478 million tons, a year-on-year increase of 1.6%. The main business income showed a steady increase, from 328.972 billion yuan in 2012 to 573.475 billion yuan in 2017. The total profit was 48.644 billion yuan, but profit margins remain low (8.48% in 2017).(3,3,3-Trifluoropropyl)Methyldichlorosilane f you’ve traveled in or transited through mainland China, you won’t be allowed into New Zealand unless you’re a New Zealand national.Most foreign drugmakers offered Beijing the lowest prices globally in a recent round of negotiations in order to get some of their new products included in national insurance program, a move that will help them gain access to more patients in less-affluent cities, officials said on Thursday.